ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
Nova Ltd. leads in integrated, in-line materials metrology, capitalizing on rising chip complexity and AI-driven demand. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback